Skip to content

Author

Wiktoria Bębenek

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

Combined disulfiram and MK-8776 treatment reveals cell line–dependent antitumor activity in different 3D ovarian cancer subtypes

Disulfiram (DSF) is an FDA-approved drug with pleiotropic anticancer activity, including induction of cellular stress and effects on stemness-associated phenotypes in ovarian cancer. Here, we investigated whether DSF enhances the antitumor efficacy of the CHK1 inhibitor MK-8776 in ovarian cancer models, with emphasis...

Wiktoria Bębenek, A. Gajek, A. Rogalska · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.